Moreover, Cu-ATSM uptake is noticeably greater in grade IV gliomas compared with grade III gliomas and correlates with HIF-1α expression, a marker of hypoxia (Tateishi et al. 2013). This evidence concerns the gene HIF1A and central nervous system cancer.